Yarrow Bioscience (YARW) Current Leases (2019 - 2025)
Yarrow Bioscience's (YARW) quarterly Current Leases came in at $25000.0 in Q2 2025, down 79.17% YoY from $120000.0 in Q2 2024, and down 60.32% on a QoQ basis from $63000.0 in Q1 2025.
Yarrow Bioscience (YARW) Current Leases (2019 - 2025) Analysis & Trends
Yarrow Bioscience (YARW) has 7 years of Current Leases data on file, last reported at $25000.0 in Q2 2025.
- Quarterly Current Leases fell 79.17% year-over-year to $25000.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $25000.0 (down 79.17% YoY) and the FY2024 annual result came in at $99000.0, down 13.91% from the prior year.
- Current Leases retreated to $25000.0 in Q2 2025, from $63000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $647000.0 in Q1 2021 to a low of $25000.0 in Q2 2025.
- A 5-year average of $192307.7 and a median of $117000.0 in 2024 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2022 — Current Leases plunged 92.86% — and 2024, when it retreated 13.91%.
- Tracing YARW's Current Leases over 5 years: stood at $349000.0 in 2021, then tumbled by 91.12% to $31000.0 in 2022, then soared by 270.97% to $115000.0 in 2023, then fell by 13.91% to $99000.0 in 2024, then plunged by 74.75% to $25000.0 in 2025.
- The last three Current Leases figures came in at $25000.0 (Q2 2025), $63000.0 (Q1 2025), and $99000.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 45.93 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 6.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Yarrow Bioscience | 32.54 Mn | 9.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 25,000.00 |
| Mar 31, 2025 | 63,000.00 |
| Dec 31, 2024 | 99,000.00 |
| Sep 30, 2024 | 123,000.00 |
| Jun 30, 2024 | 120,000.00 |
| Mar 31, 2024 | 117,000.00 |
| Dec 31, 2023 | 115,000.00 |
| Jun 30, 2022 | 31,000.00 |
| Mar 31, 2022 | 100,000.00 |
| Dec 31, 2021 | 349,000.00 |
| Sep 30, 2021 | 277,000.00 |
| Jun 30, 2021 | 434,000.00 |
| Mar 31, 2021 | 647,000.00 |
| Dec 31, 2020 | 757,000.00 |
| Sep 30, 2020 | 1.10 Mn |
| Jun 30, 2020 | 1.25 Mn |
| Mar 31, 2020 | 1.01 Mn |
| Dec 31, 2019 | 1.09 Mn |